Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis
Eight-week results from the TRuE-AD4 trial demonstrate treatment with Opzelura® (ruxolitinib cream) significantly improved the clinical signs of atopic dermatitis... Read more.
EDS Service Solutions to Showcase Comprehensive Staffing and Workforce Solutions at The Hospitality Show 2025
ATLANTA–(BUSINESS WIRE)–#CarRentalIndustry–EDS Service Solutions (EDS) announced it will exhibit at The Hospitality Show 2025, Oct. 27-28 at the... Read more.
MidWestOne Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MidWestOne Financial Group, Inc. – MOFG
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. – ADVM
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. – ADVM
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.
SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis
Four presentations highlight 12-month clinical outcomes, as well as MRI-assessed joint protection and patient perspectives supporting the SetPoint System as first-of-its-kind... Read more.
Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025
Positive, early results from 71 patients treated across three disease cohorts – systemic sclerosis, systemic lupus erythematosus and idiopathic inflammatory myopathies... Read more.
MultiBank Group and Khabib Nurmagomedov Launch an Exclusive Worldwide Multi-Billion-Dollar Joint Venture to Build the World’s First Regulated Tokenized Sports Ecosystem
DUBAI, United Arab Emirates–(BUSINESS WIRE)–#Blockchain—MultiBank Group, the world’s largest financial derivatives institution, has entered into... Read more.
Uptiq Unveils Qore at Money20/20: The AI Platform That Turns Financial Services Teams Into Builders
LAS VEGAS–(BUSINESS WIRE)–#AI—Uptiq.ai, the leader in AI infrastructure for Financial Services, today announced it will unveil Uptiq Qore at Money20/20... Read more.
AvionTEq Wraps Up a Successful NBAA-BACE 2025 with Strong Interest in FDT uQAR2w Wi-Fi QAR and Exclusive Show Offers
LOS ANGELES–(BUSINESS WIRE)–#AviationIndustry–AvionTEq, a trusted global supplier of aviation test equipment and avionics testing solutions, successfully... Read more.